PURPOSE: The Department of Health and Senior Services has prepared a list of all drugs falling within the purview of controlled substances.

1. (1) Schedules of Controlled Substances.

   1. (A) Schedule I shall consist of the drugs and other substances, by whatever official name, common or usual name, chemical name, or brand name designated, listed in this section. Each drug or substance has been assigned the Drug Enforcement Administration (DEA) Controlled Substances Code Number set forth opposite it.

      1. 1. Opiates. Unless specifically excepted or unless listed in

another schedule, any of the following opiates, including their isomers, esters, ethers, salts, and salts of isomers, esters, and ethers, whenever the existence of such isomers, esters, ethers, and salts is possible within the specific chemical designation:

1. A. Acetyl-alpha-methylfentanyl (N-(1-(1-methyl-2-phenethyl)- 4-piperidinyl)-N- phenylacetamide)
2. B. Acetylmethadol
3. C. Acetyl fentanyl (N-(1- phenethylpiperidin-4-yl)- N-phenylacetamide)
4. D. N-(1-phenethylpiperidin- 4-yl)-N-phenylacrylamide, its isomers, esters, ethers, salts, and salts of isomers, esters, and ethers (other names: acryl fentanyl, acryloylfentanyl)
5. E. AH-7921(3,4-dichloro- N-[(1-dimethylamino) cyclohexylmethyl] benzamide)
6. F. Allylprodine
7. G. Alphacetylmethadol (except levoalphacetylmethadol also known as levo-alphaacetylmethadol levothadyl acetate or LAAM)
8. H. Alphameprodine
9. I. Alphamethadol
10. J. Alpha-methylfentanyl (N-1-(alphamethyl-betaphenyl) ethyl-4-piperidyl) propionanilide; 1-(1-methyl- 2-phenylethyl)-4 ((N- propanilido) piperidine)
11. K. Alpha-methylthiofentanyl (N-(1-methyl-2-(2-thienyl) ethyl-4-piperidinyl)-N- phenylpropanamide)
12. L. Benzethidine
13. M. Betacetylmethadol
14. N. Beta-hydroxyfentanyl (N-(1-(2-hydroxy-2- phenethyl)-4-piperidinyl)- N-phenylpropanamide)

1. O. Beta-hydroxy-3- methylfentanyl (other name: N-(1-(2-hydroxy-2-phenethyl)- 3-methyl-4-piperidinyl)-N- phenylpropanamide)
2. P. N-[1-[2-hydroxy-2-(thiophen- 2-yl) ethyl]piperidin-4-yl]- N-phenylpropionamide (other names: beta-hydroxythiofentanyl)
3. Q. Betameprodine
4. R. Betamethadol
5. S. beta-Methyl fentanyl (N-phenyl-N-(1-(2- phenylpropyl)piperidin-4-yl) propionamide (Other name: β-methyl fentanyl)
6. T. beta'-Phenyl fentanyl (N-(1-phenethylpiperidin-4-yl)- N,3-diphenylpropanamide (other names: β'-phenyl fentanyl; 3-phenylpropanoyl fentanyl)
7. U. Betaprodine
8. V. Clonitazene
9. W. Crotonyl fentanyl ((E)-N-(1- phenethylpiperidin-4-yl)-N- phenylbut-2-enamide)
10. X. N-(1-phenethylpiperidin- 4-yl)-N- Phenylcyclopentanecarboxamide (other name: cyclopentyl fentanyl)
11. Y. Cyclopropyl fentanyl (N-(1- phenethylpiperidin-4-yl)-N- phenylcyclopropanecarboxamide)
12. Z. Dextromoramide AA. Diampromide BB. Diethylthiambutene
13. CC. Difenoxin
14. DD. Dimenoxadol EE. Dimepheptanol FF. Dimethylthiambutene GG. Dioxaphetyl butyrate HH. Dipipanone
15. II. Ethylmethylthiambutene JJ. Etonitazene KK. Etoxeridine
16. LL. Fentanyl carbamate (ethyl (1-phenethylpiperidin-4-yl) (phenyl)carbamate)
17. MM. N-(4-fluorophenyl)-N- (1-phenethylpiperidin-4- yl)isobutyramide, its isomers, esters, ethers, salts, and salts of isomers, esters, and ethers (other names: 4-fluoroisobutyryl fentanyl, parafluoroisobutyryl fentanyl) NN. 2'-Fluoro orthofluorofentanyl (N-(1-(2- fluorophenethyl) piperidin- 4-yl)-N-(2-fluorophenyl) propionamide (other names: 2'-fluoro 2-fluorofentanyl) OO. N-(1-phenethylpiperidin- 4-yl)-N-phenylfuran-2- carboxamide (other names: furanyl fentanyl) PP. Furethidine QQ. Hydroxypethidine RR. N-(1-phenethylpiperidin- 4-yl)-N-phenylisobutyramide (other name: isobutyryl fentanyl) SS. Isotonitazene (N,N-diethyl-2-(2- (4-isopropoxybenzyl)-5-nitro- 1H-benzimidazol-1-yl) ethan-1-amine) TT. Ketobemidone UU. Levomoramide
18. VV. Levophenacylmorphan WW. Methoxyacetyl fentanyl (2-methoxy-N-(1- phenethylpiperidin-4-yl)- N-phenylacetamide
19. XX. 4'-Methyl acetyl fentanyl (N-(1-(4-methylphenethyl) piperidin-4-yl)-N- phenylacetamide) YY. 3-Methylfentanyl (N-(3- methyl-1-(2-phenylethyl)-4- piperidyl)-N- phenylproanamide), its optical and geometric isomers, salts, and salts of isomers ZZ. 3-Methylthiofentanyl (N- (3-methyl-1-(2- thienyl)ethyl-4-piperidinyl)- N-phenylpropanamide) AAA. Morpheridine BBB. MPPP (1-methyl-4-phenyl-4- propionoxypiperidine)
20. CCC. MT–45 (1-cyclohexyl- 4-(1,2-diphenylethyl) piperazine)
21. DDD. Noracymethadol EEE. Norlevorphanol FFF. Normethadone GGG. Norpipanone HHH. N-(2-fluorophenyl)-2-methoxy-N-(1- phenethylpiperidin-4- yl)acetamide, its isomers, esters, ethers, salts, and salts of isomers, esters, and ethers (other name: ocfentanil)
22. III. ortho-Fluoroacryl fentanyl (N-(2- fluorophenyl)-N-(1- phenethylpiperidin-4-yl) acrylamide) (9560) JJJ. ortho-Fluorobutyryl fentanyl (N-(2-fluorophenyl)-N-(1- phenethylpiperidin-4-yl) butyramide (other name: 2-fluorobutyryl fentanyl) KKK. ortho-Fluorofentanyl (N-(2- fluorophenyl)-N-(1- phenethylpiperidin-4-yl) propionamide); other name: 2-fluorofentanyl)
23. LLL. ortho-Fluoroisobutyryl fentanyl (N-(2- fluorophenyl)-N-(1- phenethylpiperidin-4- yl)isobutyramide)
24. MMM. ortho-Methyl acetylfentanyl (N-(2-methylphenyl)-N-(1- phenethylpiperidin-4-yl) acetamide (other name: 2-methyl acetylfentanyl) NNN. ortho-Methyl methoxyacetyl fentanyl (2-methoxy-N-(2- methylphenyl)-N-(1- phenethylpiperidin-4-yl) acetamide (other name: 2-methyl methoxyacetyl fentanyl) OOO. N-(4-chlorophenyl)-N- (1-phenethylpiperidin- 4-yl)isobutyramide (other name: parachloroisobutyryl fentanyl) PPP. para-Fluorobutyryl fentanyl (N-(4- fluorophenyl)-N-(1- phenethylpiperidin-4- yl)butyramide) QQQ. para-fluorofentanyl(N- (4-fluorophenyl)-N-(1-(2- phenethyl)-4-piperidinyl) propanamide RRR. para-Fluoro furanyl fentanyl (N-(4- fluorophenyl)-N-(1- phenethylpiperidin-4- yl)furan-2-carboxamide) SSS. para-Methoxybutyryl fentanyl (N-(4- methoxyphenyl)-N-(1- phenethylpiperidin-4-yl) butyramide) TTT. para-Methylfentanyl (N-(4-methylphenyl)-N- (1-phenethylpiperidin-4-yl) propionamide (other name: 4-methylfentanyl) UUU. PEPAP (1-(-2-phenethyl)- 4-phenyl-4-acetoxypiperidine)
25. VVV. Phenadoxone WWW. Phenampromide

26. XXX. Phenomorphan YYY. Phenoperidine ZZZ. Phenyl fentanyl (N-(1- phenethylpiperidin-4-yl)- N-phenylbenzamide (other name: benzoyl fentanyl) AAAA. Piritramide BBBB. Proheptazine

    1. CCCC. Properidine
    2. DDDD. Propiram EEEE. Racemoramide FFFF. N-(1-phenethylpiperidin-4-yl)- N-phenyltetrahydrofuran- 2-carboxamide, its isomers, esters, ethers, salts, and salts of isomers, esters, and ethers (other name: tetrahydrofuranyl fentanyl) GGGG. Thiofentany (N-phenyl- N-(1-(2-thienyl)ethyl-4- piperidinyl)-propanamide HHHH. Thiofuranyl fentanyl (N-(1-phenethylpiperidin- 4-yl)-N-phenylthiophene- 2-carboxamide (other

names: 2-thiofuranyl fentanyl; thiophene fentanyl)

1. IIII. Tilidine JJJJ. Trimeperidine
2. 2. Opium derivatives. Unless specifically excepted or

unless listed in another schedule, any of the following opium derivatives, its salts, isomers, and salts of isomers whenever the existence of such salts, isomers, and salts of isomers is possible within the specific chemical designation:

1. A. Acetorphine
2. B. Acetyldihydrocodeine
3. C. Benzylmorphine
4. D. Codeine methylbromide
5. E. Codeine-N-Oxide
6. F. Cyprenorphine
7. G. Desomorphine
8. H. Dihydromorphine
9. I. Drotebanol
10. J. Etorphine (except hydrochloride salt)
11. K. Heroin
12. L. Hydromorphinol
13. M. Methyldesorphine
14. N. Methyldihydromorphine
15. O. Morphine methylbromide
16. P. Morphine methylsulfonate
17. Q. Morphine-N-Oxide
18. R. Myrophine
19. S. Nicocodeine
20. T. Nicomorphine
21. U. Normorphine
22. V. Pholcodine
23. W. Thebacon
24. 3. Opiate Similar Synthetic Substances. Substances

scheduled by the United States Drug Enforcement Administration as substances that share a pharmacological profile similar to fentanyl, morphine, and other synthetic opioids, unless specifically excepted or unless listed in another schedule. These substances are—

1. A. Butyryl fentanyl (N- (1-phenethylpiperidin-4-yl)- N-phenylbutyramide)

   1. 4. Hallucinogenic substances. Unless specifically excepted

or unless listed in another schedule, any material, compound, mixture or preparation, which contains any quantity of the following hallucinogenic substances or which contains any of its salts, isomers, and salts of isomers whenever the existence of such salts, isomers, and salts of isomers is possible within the specific chemical designation (For purposes of paragraph (1)(A)4. of this rule only, the term isomer includes the optical, position, and geometric isomers.):

Some trade or other names: etryptamine; Monase; alpha-ethyl- 1H-indole-3-ethenamine; 3-(2-aminobutyl)indole; alpha-ET; and AET;

Some trade or other names: 4-bromo-2, 5- dimethoxy-amethylphenethylamine; 4-bromo- 2, 5-DMA;

Some trade or other names: 2,5-dimethoxy-amethylphenethylamine; 2,5-DMA;

Some trade or other names: DOET;

Some trade or other names: 4-methoxy-amethylphenethylamine; paramethoxyamphetamine; PMA;

Some trade and other names: 4-methyl-2, 5- dimethoxy-amethylphenethylamine; DOM; and STP;

1. B. U–47700 (3,4-Dichloro- N-[2-(dimethylamino) cyclohexyl]-N- methylbenzamide)
2. C. N-(1-phenethylpiperidin- 4-yl)-N-phenylpentanamide (other name: valeryl fentanyl)
3. A. Alpha-ethyltryptamine
4. B. 4-bromo-2,5-dimethoxyamphetamine
5. C. 4-bromo-2,5-dimethoxyphenethylamine
6. D. 2,5-dimethoxyamphetamine
7. E. 2,5-dimethoxy-4-ethylamphetamine
8. F. 2,5-dimethoxy-4-(n)-propylthiophenethylamine (other name: 2C-T-7)
9. G. 2-(2,5-Dimethoxy-4-(n)-propylphenyl) ethanamine (2C-P)
10. H. 2-(2,5-Dimethoxy-4-ethylphenyl) ethanamine (2C-E)
11. I. 2-(2,5-Dimethoxy-4-methylphenyl) ethanamine (2C-D)
12. J. 2-(2,5-Dimethoxy-4-nitrophenyl) ethanamine (2C-N)
13. K. 2-(2,5-Dimethoxyphenyl) ethanamine (2C-H)
14. L. 2-(4-Chloro-2,5-dimethoxyphenyl) ethanamine (2C-C)
15. M. 2-(4-Ethylthio-2,5-dimethoxyphenyl) ethanamine (2C-T-2)
16. N. 2-(4-Iodo-2,5-dimethoxyphenyl) ethanamine (2C-I)
17. O. 2-(4-Isopropylthio)-2,5-dimethoxyphenyl) ethanamine (2C-T-4)
18. P. 4-methoxyamphetamine
19. Q. 5-methoxy-3,4-methylenedioxyamphetamine
20. R. 4-methyl-2,5-dimethoxyamphetamine
21. S. 3,4-methylenedioxyamphetamine
22. T. 3,4-methylenedioxymethamphetamine(MDMA)

23. U. 3,4-methylenedioxy-N- ethylamphetamine (also known as N-ethylalphamethyl-3,4 (methylenedioxy) phenethylamine, N-ethyl MDA, MDE, and MDEA)

    1. V. N-hydroxy-3,4- methylenedioxyamphetamine (also known as N-hydroxyalpha-methyl-3,4 (methylenedioxy) phenethylamine and N- hydroxy MDA)
    2. W. 3,4,5-trimethoxyamphetamine
    3. X. 5-MeO-DMT or 5-methoxy- N,N-dimethyltryptamine
    4. Y. Alpha-methyltryptamine
    5. Z. Bufotenine

Some trade and other names: 3-(b-Dimethylaminoethyl)- 5-hydroxyindole; 3-(2-dimethylaminoethyl)-5-indolol; N-dimethylserotonin; 5-hydroxy-N, N-dimethyltryptamine; mappine; AA. Diethyltryptamine Some trade and other names: N, N-Diethyltryptamine; DET; BB. Dimethyltryptamine Some trade or other names: DMT;

1. CC. 5-methoxy-N,N-diisopropyltryptamine (other name: 5-MeODIPT)
2. DD. Ibogaine

Some trade and other names: 7-Ethyl- 6,6β,7,8,9,10,12,13- octahydro-2-methoxy-6, 9-methano-5H-pyrido [1',2':1,2] azepino[5,4-b] indole; Tabernanthe iboga; EE. Lysergic acid diethylamide FF. Marihuana Some trade or other names: marijuana; GG. Mescaline HH. Parahexyl Some trade or other names: 3-Hexyl-1- hydroxy-7,8,9,10- tetrahydro-6,6,9-trimethyl- 6H-dibenzo[b,d]pyran; Synhexyl;

1. II. Peyote

Meaning all parts of the plant presently classified botanically as Lophophora williamsii Lemaire, whether growing or not; the seeds thereof; any extract from any part of such plant; and every compound, manufacture, salt, derivative, mixture, or preparation of such plant, its seeds, or extracts; JJ. N-ethyl-3-piperidyl benzilate KK. N-methyl-3-piperidyl benzilate

1. LL. Psilocybin
2. MM. Psilocyn NN. Tetrahydrocannabinols naturally contained

a plant of the genus Cannabis (cannabis 7370 plant), as well as synthetic equivalents of the substances contained in the cannabis plant or in the resinous extractives of such plant, and/or synthetic substances, derivatives, and their isomers, or both, with similar chemical structure and pharmacological activity to those substances contained in the plant, such as the following:

1. (I) 1 cis or trans tetrahydrocannabinol and their optical

isomers;

1. (II) 6 cis or trans tetrahydrocannabinol and their

optical isomers;

1. (III) 3,4 cis or trans tetrahydrocannabinol and its

optical isomers; and

1. (IV) Since nomenclature of these substances is not

internationally standardized, compounds of these structures, regardless of numerical designation of atomic positions are covered; OO. Ethylamine analog of phencyclidine Some trade or other names: N-ethyl-1- phenylcyclohexylamine, (1-phenylcyclohexyl) ethylamine, N-(1-phenylcyclohexyl)- ethylamine, cyclohexamine, PCE; Some trade or other names: 1-(1-phenylcyclohexyl)-pyrrolidine PCPy, PHP;

Some trade or other names: 1-(1-(2-thienyl)- cyclohexyl)- piperidine, 2-thienyl analog of phencyclidine, TPCP, TCP;

7390 Some other names: TCPy;

N,

in

PP. Pyrrolidine analog of phencyclidine

QQ. Thiophene analog of phencyclidine

RR. 1-(1-(2-thienyl)cyclohexyl) pyrrolidine

SS. Salvia divinorum TT. Salvinorin A UU. 3-Fluoromethcathinone VV. 4-Fluoromethcathinone WW. Mephedrone, or 4- methylmethcathinone XX. Methylenedioxypyrovalerone, MDPV, or (1-(1,3-Benzodioxol-5-yl)- 2-(1-pyrrolidinyl)-1- pentanone YY. Methylone, or 3,4- Methylenedioxymethcathinone ZZ. Quinolin-8-yl 1-pentyl- 1Hindole-3-carboxylate (PB-22; QUPIC) AAA. Quinolin-8-yl 1-(5- fluoropentyl)-1H-indole- 3-carboxylate (5-fluoro- PB-22; 5F-PB-22) BBB. N-(1-amino-3-methyl-1- oxobutan-2-yl)-1- (4-fluorobenzyl)-1Hindazole- 3-carboxamide (AB-FUBINACA) CCC. N-(1-amino-3, 3-dimethyl-1- oxobutan-2-yl)-1-pentyl- 1H-indazole-3-carboxamide (ADB-PINACA) DDD. (1-pentyl-1H-indol-3-yl) (2,2,3,3-tetramethylcyclopropyl) methanone (other names: UR-144, 1-pentyl-3-(2,2,3,3- tetramethylcyclopropoyl)indole) EEE. [1-(5-fluoro-pentyl)- 1Hindol-3-yl](2,2,3,3- tetramethylcyclopropyl) methanone (other names: 5-fluoro-UR-144, 5-F-UR- 144, XLR11, 1-(5-fluoropentyl)-3-(2,2,3,3- tetramethylcyclopropoyl)indole) FFF. N-(1-adamantyl)-1-pentyl- 1Hindazole-3-carboxamide (other names: APINACA, AKB48) GGG. 2-(4-iodo-2,5- dimethoxyphenyl)-N-(2- methoxybenzyl)ethanamine (other names: 251-NBOMe; 2C-I- NBOMe; 25I; Cimbi-5) HHH. 2-(4-chloro-2,5- dimethoxyphenyl)-N-(2- methoxybenzyl)ethanamine (other names: 25C- NBOMe; 2C-C-NBOMe; 25C; Cimbi-82) III. 2-(4-bromo-2,5- dimethoxyphenyl)-N-(2- methoxybenzyl)ethanamine (other names: 25B- NBOMe; 2C-B-NBOMe; 25B; Cimbi-36) JJJ. 4-methyl-N-ethylcathinone (other names: 4-MEC; 2- (ethylamino)-1-(4- methylphenyl)propan-1-one) KKK. 4-methyl-alphapyrrolidinopropiophenone, (other names: 4-MePPP; MePPP; 4-methyl- α-pyrrolidinopropiophenone; 1-(4-methylphenyl)-2- (pyrrolidin-1-yl)-propan-1-one) LLL. alphapyrrolidinopentiophenone (other names: α-PVP; α- pyrrolidinovalerophenone; 1-phenyl-2-(pyrrolidin-1-yl)pentan-1-one) MMM. Butylone (other names: bk-MBDB; 1-(1,3- benzodioxol-5-yl)-2- (methylamino)butan-1-one) NNN. Pentedrone (other names: α- methylaminovalerophenone; 2-(methylamino)-1-phenylpentan-1-one) OOO. Pentylone (other names: bk-MBDP; 1-(1,3- benzodioxol-5-yl)-2- (methylamino)pentan-1-one) PPP. Naphyrone (other names: naphthylpyrovalerone; 1- (naphthalen-2-yl)-2- (pyrrolidin-1-yl)pentan-1-one) QQQ. alpha-pyrrolidinobutiophenone (other names: α-PBP; 1-phenyl-2-(pyrrolidin-1-yl)butan-1-one) RRR. N-(1-amino-3-methyl-1- oxobutan-2-yl)-1- (cyclohexylmethyl)- 1H-indazole-3-carboxamide (other names: AB-CHMINACA) SSS. N-(1-amino-3-methyl-1- oxobutan-2-yl)-1-pentyl- 1Hindazole-3-carboxamide (other names: AB-PINACA) TTT. [1-(5-fluoropentyl)- 1H-indazol-3-yl](naphthalen- 1-yl)methanone (other names: THJ-2201) UUU. N-(1-amino-3,3-dimethyl- 1-oxobutan-2-yl)-1- (cyclohexylmethyl)- 1H-indazole-3-carboxamide (other names: MAB- CHMINACA; ADB-CHMINACA) VVV. methyl 2-(1-(5-fluoropentyl)- 1H-indazole-3-carboxamido)-3,3- dimethylbutanoate (other names: 5F–ADB; 5F–MDMB–PINACA) WWW. methyl 2-(1-(5-fluoropentyl)- 1H-indazole-3-carboxamido)-3- methylbutanoate (other names: 5F–AMB) XXX. N-(adamantan-1-yl)-1-(5- fluoropentyl)-1H-indazole- 3-carboxamide (other names: 5F–APINACA, 5F– AKB48) YYY. N-(1-amino-3,3-dimethyl- 1-oxobutan-2-yl)-1-(4- fluorobenzyl)-1H-indazole- 3-carboxamide (other names: ADB–FUBINACA) ZZZ. methyl 2-(1-(cyclohexylmethyl)- 1H-indole-3-carboxamido)-3,3- dimethylbutanoate (other names: MDMB–CHMICA, MMB–CHMINACA) AAAA. methyl 2-(1-(4-fluorobenzyl)- 1H-indazole-3-carboxamido)-3,3- dimethylbutanoate (other names: MDMB–FUBINACA) BBBB. methyl 2-(1-(4-fluorobenzyl)-1H- indazole-3-carboxamido)-3- methylbutanoate (other names: FUB–AMB, MMB– FUBINACA, AMB–FUBINACA) CCCC. 1-(1,3-benzodioxol- 5-yl)-2-(ethylamino) propan-1-one (ethylone) DDDD. Naphthalen-1-yl 1- (5-fluoropentyl)-1H- indole-3-carboxylate (other names: NM2201; CBL2201) EEEE. N-(1-amino-3-methyl- 1-oxobutan-2-yl)-1- (5-fluoropentyl)-1H- indazole-3-carboxamide (other name: 5F-AB-PINACA) FFFF. 1-(4-cyanobutyl)-N-(2- phenylpropan-2-yl)-1H- indazole-3-carboxamide (other names: 4-CN- CUMYLBUTINACA; 4-cyano-CUMYL- BUTINACA; 4-CN- CUMYLBINACA; CUMYL-4CNBINACA; SGT-78) GGGG. methyl 2-(1-(cyclohexylmethyl)-1H- indole-3-carboxamido)-3- methylbutanoate (other names: MMB- CHMICA; AMB-CHMICA) HHHH. 1-(5-fluoropentyl)-N- (2-phenylpropan-2-yl)- 1H-pyrrolo[2,3-b] pyridine-3-carboxamide (other name: 5F-CUMYL-P7AICA) (7021) IIII. N-ethylpentylone (other names: ephylone, 1-(1,3- benzodioxol-5-yl)-2- (ethylamino)-pentan-1-one) JJJJ. methyl 2-(1-(4-fluorobutyl)- 1H-indazole-3-carboxamido)-3, 3-dimethylbutanoate (4F–MDMB–BINACA, 4F–MDMB–BUTINACA) KKKK. 1-(4-methoxyphenyl)-N- methylpropan-2-amine (other names: paramethoxymethamphetamine, PMMA) LLLL. ethyl 2-(1-(5-fluoropentyl)- 1H-indazole-3-carboxamido)-3,3- dimethylbutanoate (other name: 5F-EDMB-PINACA) MMMM. methyl 2-(1-(5-fluoropentyl)- 1H-indole-3-carboxamido)-3,3- Dimethylbutanoate (other names: 5F-MDMB-PICA; 5F-MDMB-2201) NNNN. N-(adamantan-1-yl)-1-(4- fluorobenzyl)-1H-indazole-3- carboxamide (other names: FUB-AKB48; FUB-APINACA; AKB48 N-(4-FLUOROBENZYL)) OOOO. 1-(5-fluoropentyl)-N-(2- phenylpropan-2-yl)-1H- indazole-3-carboxamide (other names: 5F-CUMYL-PINACA; SGT-25) PPPP. (1-(4-fluorobenzyl)-1H- indol-3-yl)(2,2,3,3-tetramethylcyclopropyl) methanone (other name: FUB-144) QQQQ. N-Ethylhexedrone (other names: α-ethylaminohexanophenone; 2- (ethylamino)-1-phenylhexan-1-one) RRRR. alpha-Pyrrolidinohexanophenone (other names: α-PHP; α- pyrrolidinohexanophenone; 1-phenyl-2-(pyrrolidin-1-yl)hexan-1-one) SSSS. 4-Methyl-alpha-ethylaminopentiophenone (other names: 4-MEAP; 2-(ethylamino)-1- (4-methylphenyl)pentan-1-one) TTTT. 4'-Methyl-alpha-pyrrolidinohexiophenone (other names: MPHP; 4'-methylalpha-pyrrolidinohexanophenone; 1- (4-methylphenyl)-2-(pyrrolidin-1-yl)hexan- 1-one) UUUU. alpha-Pyrrolidinoheptaphenone (other names: PV8; 1-phenyl-2- (pyrrolidin-1-yl)heptan-1-one) VVVV. 4'-Chloro-alpha-pyrrolidinovalerophenone (other names: 4-chloro-α-PVP; 4'-chloro-α- pyrrolidinopentiophenone; 1-(4- chlorophenyl)-2-(pyrrolidin-1-yl) pentan- 1-one) WWWW. 2-(ethylamino)-2- (3-methoxyphenyl)cyclohexan- 1-one (methoxetamine, MXE) XXXX. Synthetic cannabinoids: Unless specifically exempted or unless listed in another schedule, any material, compound, mixture, or preparation which contains any quantity of the following substances, or which contains their salts, isomers, and salts of isomers whenever the existence of such salts, isomers, and salts of isomers is possible within the specific chemical designation:

1. (I) Any compound

7543 3-(1-naphthoyl)indole by substitution at the nitrogen atom of the indole ring by alkyl, haloalkyl, alkenyl, cycloalkylmethyl, cycloalkylethyl, 1-(N-methyl-2-piperidinyl)methyl or group, whether or not further substituted in the indole ring to any extent, whether or not substituted in the naphthyl ring to any extent. Including, but not limited to:

1. (II) Any compound

3-(1-naphthoyl)pyrrole by atom of the pyrrole ring by alkyl, haloalkyl, alkenyl, cycloalkylmethyl, cycloalkylethyl, 1-(N-methyl-2- piperidinyl) methyl or 2-(4-morpholinyl)ethyl group, whether or not further substituted in the pyrrole ring to any extent, whether or not substituted in the naphthyl ring to any extent;

1. (III) Any compound

1-(1-naphthylmethyl)indene 3-position of the indene ring by alkyl, haloalkyl, alkenyl, cycloalkylmethyl, cycloalkylethyl, 1-(N-methyl-2- piperidinyl) methyl or 2-(4-morpholinyl)ethyl group, whether or not further substituted in the indene ring to any extent, whether or not substituted in the naphthyl ring to any extent;

1. (IV) Any compound structurally derived

3-phenylacetylindole by atom of the indole ring with alkyl, haloalkyl, alkenyl, cycloalkylmethyl, cycloalkylethyl, 1-(N-methyl-2- piperidinyl) methyl or 2-(4-morpholinyl)ethyl group, whether or not further substituted in the indole ring to any extent, whether or not substituted in the phenyl ring to any extent. Including, but not limited to: structurally derived or 1Hindol-3-yl-(1-naphthyl)methane

2-(4-morpholinyl)ethyl

1. (a) AM2201, or 1-(5-fluoropentyl)-3- (1-naphthoyl)indole
2. (b) JWH-007, or 1-pentyl-2-methyl- 3-(1-naphthoyl)indole
3. (c) JWH-015, or 1-propyl-2-methyl-3-(1- naphthoyl)indole
4. (d) JWH-018, or 1-pentyl- 3-(1-naphthoyl)indole
5. (e) JWH-019, or 1-hexyl- 3-(1-naphthoyl)indole
6. (f) JWH-073, or 1-butyl- 3-(1-naphthoyl)indole
7. (g) JWH-081, or 1-pentyl-3-(4-methoxy-1- naphthoyl)indole
8. (h) JWH-098, or 1-pentyl-2-methyl-3-(4- methoxy-1-naphthoyl)indole
9. (i) JWH-122, or 1-pentyl-3-(4-methyl-1- naphthoyl)indole
10. (j) JWH-164, or 1-pentyl-3-(7-methoxy-1- naphthoyl)indole
11. (k) JWH-200, or 1-(2-(4-(morpholinyl)ethyl))- 3-(1-naphthoyl)indole
12. (l) JWH-210, or 1-pentyl-3-(4-ethyl-1- naphthoyl)indole

13. (m) JWH-398, or 1-pentyl-3-(4-chloro-1- naphthoyl)indole structurally derived substitution at the nitrogen

    structurally derived

    by substitution at

    substitution at the nitrogen

14. (a) JWH-201, or 1-pentyl-3-(4- methoxyphenylacetyl)indole
15. (b) JWH-203, or 1-pentyl-3-(2-chlorophenylacetyl)indole
16. (c) JWH-250, or 1-pentyl- 3-(2-methoxypheny-lacetyl)indole from

from

from the

from

1. (d) JWH-251, or 1-pentyl-3-(2- methylphenylacetyl)indole
2. (e) RCS-8, or 1-(2-cyclohexylethyl)-3-(2- methoxypheny-lacetyl)indole
3. (V) Any compound structurally derived

2-(3-hydroxycyclohexyl)phenol by substitution at 5-position of the phenolic ring by alkyl, haloalkyl, alkenyl, cycloalkylmethyl, cycloalkylethyl, 1-(N-methyl-2-piperidinyl) methyl or 2-(4-morpholinyl)ethyl group, whether or not substituted in the cyclohexyl ring to any extent. Including, but not limited to:

1. (a) CP 47,497 & homologues, or 2-[(1R,3S)-3-

hydroxycyclohexyl]-5-(2-methyloctan-2-yl)phenol), side chain n=5, and homologues where side chain n-4, 6, or 7 7297, 7298

1. (VI) Any compound containing a 3- (benzoyl)indole

structure with substitution at the nitrogen atom of the indole ring by alkyl, haloalkyl, alkenyl, cycloalkylmethyl, cycloalkylethyl, 1-(N-methyl-2-piperidinyl)methyl 2-(4-morpholinyl)ethyl group, whether or not further substituted in the indole ring to any extent and whether or not substituted in the phenyl ring to any extent. Including, but not limited to:

1. (a) AM-694, or 1-(5-fluoropentyl)-3-(2- iodobenzoyl)indole
2. (b) RCS-4, or 1-pentyl-3-(4- methoxybenzoyl)indole (SR-19 and RCS-4)
3. (VII) CP 50,556-1, or [(6S,6aR,9R,10aR)-9-hydroxy-6-

methyl-3-[(2R)-5-phenylpentan-2-yl]oxy-5,6,6a,7,8,9,10,10aoctahydrophenanthridin- 1-yl] acetate; (VIII) HU-210, or (6aR,10aR)-9-(hydroxymethyl)-6,6- dimethyl-3-(2-methyloctan-2-yl)-6a,7,10,10a-tetrahydrobenzo[c] chromen-1-ol;

1. (IX) HU-211, or Dexanabinol,(6aS,10aS)-9-

(hydroxymethyl)- 6,6-dimethyl-3-(2-methyloctan-2-yl)- 6a,7,10,10a-tetrahydrobenzo[c]chromen-1-ol;

1. (X) Dimethylheptylpyran, or DMHP.
2. 5. Depressants. Unless specifically excepted or unless

listed in another schedule, any material compound, mixture, or preparation which contains any quantity of the following substances having a depressant effect on the central nervous system, including its salts, isomers, and salts of isomers whenever the existence of such salts, isomers, and salts of isomers is possible within the specific chemical designation:

1. A. Gamma-hydroxybutyric acid and other names GHB; gamma-hydroxybutyrate; 4-hydroxybutyrate; 4-hydroxybutonic acid; sodium oxybate; sodium oxybutryrate
2. B. Mecloqualone
3. C. Methaqualone
4. 6. Stimulants. Unless specifically excepted or unless listed

in another schedule, any material, compound, mixture, or preparation which contains any quantity of the following substances having a stimulant effect on the central nervous system, including its salts, isomers, and salts of isomers:

1. A. Aminorex

Some trade or other names: aminoxaphen; 2-amino-5-phenyl-2- oxazoline; 4,5-dihydro-5-phenyl-2-oxazolamine;

1. B. N-benzylpiperazine (some other names: BZP, 1- benzylpiperzaine)

from the

where Some trade or other names: 2-(methylamino)-propiophenone; alpha-(methylamino) phenylpropan-1-one; monomethylpropion; methylcathinine; AL-464; AL-422; AL-463 and URI 432; or

(some other names: N,N-alpha-trimethylbenzeneethanamine; N,N-alpha-trimethylphenethylamine)

1. 7. A temporary listing of substances subject to emergency

scheduling under federal law shall include any material, compound, mixture, or preparation which contains any quantity of the following substances:

not otherwise listed under another Administration Controlled Substance Code Number, and for which no exemption or approval is in effect under section 505 of the Federal Food, Drug, and Cosmetic Act 21 U.S.C. 355, that is structurally related to fentanyl by one (1) or more of the following modifications:

phenethyl group by any monocycle, whether or not further substituted in or on the monocycle;

alkyl, alkenyl, alkoxyl, hydroxyl, halo, haloalkyl, amino, or nitro groups;

alkyl, alkenyl, alkoxyl, ester, ether, hydroxyl, halo, haloalkyl, amino, or nitro groups;

aromatic monocycle whether or not further substituted in or on the aromatic monocycle; and/or

another acyl group.

1. C. Cathinone (Some trade or other names: 2-amino-1- phenyl-1-propanone, alphaaminopropiophenone, 2-aminopropiophenone and norephedrone) 1235
2. D. 4,4'-Dimethylaminorex (4,4'-DMAR; 4,5-dihydro-4- methyl-5-(4-methylphenyl)-2- oxazolamine; 4-methyl-5-(4- methylphenyl)-4,5-dihydro- 1,3-oxazol-2-amine) 1595
3. E. Fenethylline 1503

4. F. Methcathinone 1237

   propiophenone; 2-(methylamino)-1- alpha-N-methylaminopropiophenone; ephedrone; N-methylcathinone;

5. G. 4-methoxymethcathinone
6. H. cis-4-methylaminorex (cis-4,5-dihydro-4-methyl- 5-phenyl-2-oxazolamine) 1590
7. I. 4-Methyl-alphapyrrolidinobutiophenone, or MPBP
8. J. N-ethylamphetamine 1475
9. K. N,N-dimethylamphetamine 1480

10. A. Fentanyl-related substances, their isomers, esters, ethers, salts, and salts of isomers, esters, and ethers. 9850

    1. (I) Fentanyl-related substance means any substance

       1. (a) Replacement of the phenyl portion of the
       2. (b) Substitution in or on the phenethyl group with
       3. (c) Substitution in or on the piperidine ring with
       4. (d) Replacement of the aniline ring with any
       5. (e) Replacement of the N-propionyl group by

11. B. 1-(1-(1-(4-bromophenyl) ethyl)piperidin-4-yl)-1, 3- dihydro-2H-benzo[d]imidazol- 2-one, its isomers, esters, ethers, salts, and salts of isomers, esters, and ethers (Other names: brorphine; 1-[1-[1-(4-bromophenyl)ethyl]-4- piperidinyl]-1,3-dihydro- 2H-benzimidazol-2-one) 9098

    1. C. 2-(2-(4-butoxybenzyl)-5-nitro-1H- benzimidazol-1-yl)-N, N-diethylethan-1-amine, its isomers, esters, ethers, salts, and salts of isomers, esters and ethers (other name: Butonitazene)
    2. D. 2-(2-(4-ethoxybenzyl)-1H-benzimidazol-1-yl)-N, N-diethylethan-1-amine, its isomers, esters, ethers, salts, and salts of isomers, esters and ethers (other names: Etodesnitazene; etazene)
    3. E. N, N-diethyl-2-(2-(4-fluorobenzyl)-5-nitro- 1H-benzimidazol-1-yl)ethan-1-amine, its isomers, esters, ethers, salts, and salts of isomers, esters and ethers (other name: Flunitazene)
    4. F. N,N-diethyl-2-(2-(4-methoxybenzyl)-1H- benzimidazol-1-yl)ethan-1-amine, its isomers, esters, ethers, salts, and salts of isomers, esters and ethers (other name: Metodesnitazene)
    5. G. N, N-diethyl-2-(2-(4-methoxybenzyl)-5-nitro-1H- benzimidazol-1-yl)ethan-1-amine, its isomers, esters, ethers, salts, and salts of isomers, esters and ethers (other name: Metonitazene)
    6. H. 2-(4-ethoxybenzyl)-5-nitro-1- (2-(pyrrolidin-1-yl)ethyl) -1H-benzimidazole, its isomers, esters, ethers, salts, and salts of isomers, esters and ethers (other names: N-pyrrolidino etonitazene; etonitazepyne)
    7. I. N, N-diethyl-2-(5-nitro-2-(4-propoxybenzyl) -1H-benzimidazol-1-yl)ethan-1-amine, its isomers, esters, ethers, salts, and salts of isomers, esters and ethers (other name: Protonitazene)
    8. 8. Khat, to include all parts of the plant presently classified

botanically as catha edulis, whether growing or not; the seeds thereof; any extract from any part of such plant; and every compound, manufacture, salt, derivative, mixture, or preparation of the plant, its seed, or extracts.

1. (B) Schedule II shall consist of the drugs and other substances, by whatever official name, common or usual name, chemical name, or brand name designated, listed in this section. Each drug or substance has been assigned the Controlled Substances Code Number set forth opposite it.

   1. 1. Substances, vegetable origin, or chemical synthesis.

Unless specifically excepted or unless listed in another schedule, Schedule II shall include any of the following substances whether produced directly or indirectly by extraction from substances of vegetable origin or independently by means of chemical synthesis or by a combination of extraction and chemical synthesis:

1. A. Opium and opiate; and any salt, compound,

derivative, or preparation of opium or opiate, excluding apomorphine, thebaine-derived butorphanol, dextrorphan, nalbuphine, nalmefene, naloxegol, naloxone, and naltrexone and their respective salts, but including the following:

1. (I) Raw opium
2. (II) Opium extracts
3. (III) Opium fluid
4. (IV) Powdered opium
5. (V) Granulated opium
6. (VI) Tincture of opium
7. (VII) Codeine which is chemically equivalent or identical with any of the substances referred to in subparagraph (1)(B)1.A. of this rule shall be included in Schedule II, except that these substances shall not include the isoquinoline alkaloids of opium;

or preparation of coca leaves (including cocaine (9041) and

9764 ecgonine (9180) and their salts, isomers, derivatives, and salts of isomers and derivatives), and any salt, compound, derivative, or preparation thereof which is chemically equivalent or identical with any of these substances, except that the substances shall not include:

leaves, which extractions do not contain cocaine or ecgonine; or

straw in either liquid, solid, or powder form which contains the phenanthrene alkaloids of the opium poppy)

1. 2. Opiates. Unless specifically excepted or unless in

another schedule any of the following opiates, including its isomers, esters, ethers, salts, and salts of isomers, esters, and ethers whenever the existence of such isomers, esters, ethers,

9759 and salts is possible within the specific chemical designation, dextrorphan, and levopropoxyphene excepted:

Some other names: levo-alphaacetylmethadol, levomethadyl acetate, LAAM

(VIII) Dihydroetorphine (IX) Ethylmorphine (X) Etorphine hydrochloride (XI) Hydrocodone (XII) Hydromorphone (XIII) Metopon (XIV) Morphine (XV) Oripavine (XVI) Oxycodone (XVII) Oxymorphone (XVIII) Thebaine

1. B. Any salt, compound, derivative, or preparation thereof
2. C. Opium poppy and poppy straw

3. D. Coca leaves (9040) and any salt, compound, derivative,

   1. (I) Decocainized coca leaves or extraction of coca
   2. (II) Ioflupane;
4. E. Concentrate of poppy straw (the crude extract of poppy
5. A. Alfentanil
6. B. Alphaprodine
7. C. Anileridine
8. D. Bezitramide
9. E. Bulk Dextropropoxyphene (Non-dosage Forms)
10. F. Carfentanil
11. G. Dihydrocodeine
12. H. Diphenoxylate
13. I. Fentanyl
14. J. Isomethadone
15. K. Levo-alphacetylmethadol
16. L. Levomethorphan
17. M. Levorphanol
18. N. Metazocine
19. O. Methadone
20. P. Methadone-Intermediate, 4-cyano-2-dimethylamino- 4,4-diphenyl butane
21. Q. Moramide-Intermediate, 2- methyl-3-morpholino-1, 1-diphenylpropane-carboxylic acid
22. R. Oliceridine (N-[(3-methoxythiophen-2-yl) methyl] ({2-[(9R)-9-(pyridin-2-yl)-6-oxaspiro [4.5]decan-9-yl]ethyl})amine fumarate)

23. S. Pethidine (Meperidine)

    1. T. Pethidine-Intermediate-A, 4-cyano-1-methyl-4-phenylpiperidine
    2. U. Pethidine-Intermediate-B, ethyl-4-phenylpiperidine-4-carboxylate
    3. V. Pethidine-Intermediate-C, 1- methyl-4-phenylpiperidine- 4-carboxylic acid
    4. W. Phenazocine
    5. X. Piminodine
    6. Y. Racemethorphan
    7. Z. Racemorphan AA. Remifentanil BB. Sufentanil
    8. CC. Tapentadol
    9. DD. Thiafentanil
    10. 3. Stimulants. Unless specifically excepted or unless listed

in another schedule, any material, compound, mixture, or preparation which contains any quantity of the following substances having a stimulant effect on the central nervous system:

1. A. Amphetamine, its salts, optical isomers, and salts of its optical isomers
2. B. Lisdexamfetamine, its salts, isomers, and salts of its isomers
3. C. Methamphetamine, its salts, isomers, and salts of its isomers
4. D. Phenmetrazine and its salts
5. E. Methylphenidate
6. 4. Depressants. Unless specifically excepted or unless

listed in another schedule, any material, compound, mixture, or preparation which contains any quantity of the following substances having a depressant effect on the central nervous system, including its salts, isomers, and salts of isomers whenever the existence of such salts, isomers, and salts of isomers is possible within the specific chemical designation:

1. A. Amobarbital
2. B. Glutethimide
3. C. Pentobarbital
4. D. Phencyclidine
5. E. Secobarbital

6. 5. Hallucinogenic substances:

   1. A. Nabilone

Another name for nabilone: (±)trans-3-(1, 1- dimethylheptyl)-6, 6a,7,8,10,10a-hexahydro- 1-hydroxy-6, 6-dimethyl-9H- dibenzo(b,d) pyran-9-one.

1. B. Dronabinol [(-)-delta-9-trans tetrahydrocannabinol]

in an oral solution in a drug product approved for marketing by the United States Food and Drug Administration.

1. 6. Immediate precursors. Unless specifically excepted or

unless listed in another schedule, any material, compound, mixture, or preparation which contains any quantity of the following substances:

1. A. Immediate precursor to amphetamine and

methamphetamine:

1. (I) Phenylacetone

Some trade or other names: phenyl-2-propanone; P2P; benzyl methyl ketone; methyl benzyl ketone;

1. B. Immediate precursors to phencyclidine (PCP):

   1. (I) 1-phenylcyclohexylamine
   2. (II) 1-piperidinocyclohexanecarbonitrile (PCC)

2. C. Immediate precursor to fentanyl:

   1. (I) 4-anilino-N-phenethyl-4- piperidine (ANPP)

9233 7. Any material, compound, mixture, or preparation which contains any quantity of the following alkyl nitrites:

1. (C) Schedule III shall consist of the drugs and other substances, by whatever official name, common or usual name, chemical name, or brand name designated, listed in this section. Each drug or substance has been assigned the DEA Controlled Substances Code Number set forth opposite it.

   1. 1. Stimulants. Unless specifically excepted or unless listed

in another schedule, any material, compound, mixture, or preparation which contains any quantity of the following substances having a stimulant effect on the central nervous system, including its salts, isomers (whether optical, position, or geometric), and salts of such isomers whenever the existence of such salts, isomers, and salts of isomers is possible within the specific chemical designation:

dosage unit form containing any stimulant substances listed in Schedule II which compounds, mixtures, or preparations were listed on August 25, 1971, as excepted compounds under 21 CFR 308.32 and any other drug of the quantitive composition shown in that list for those drugs or which is the same except that it contains a lesser quantity of controlled substances 1405

1. 2. Depressants. Unless specifically excepted or unless

listed in another schedule, any material compound, mixture, or preparation which contains any quantity of the following substances having a depressant effect on the central nervous system:

or any salt thereof and one (1) or more other active medicinal ingredients which are not listed in any schedule;

or any salt of any of these drugs and approved by the Food and Drug Administration for marketing only as a suppository;

(7365) derivative of barbituric acid or any salt thereof

acid, including its salts, isomers, and salts of isomer, for which an application is approved under section 505 of the Federal Food, Drug, and Cosmetic Act;

1. (II) N-phenyl-N-(piperidin- 4-yl)propionamide (norfentanyl)

1. A. Amyl nitrite;
2. B. Butyl nitrite.
3. A. Those compounds, mixtures, or preparations in
4. B. Benzphetamine
5. C. Chlorphentermine
6. D. Clortermine
7. E. Phendimetrazine

8. A. Any compound, mixture, or preparation containing—

   1. (I) Amobarbital
   2. (II) Secobarbital
   3. (III) Pentobarbital

9. B. Any suppository dosage form containing—

   1. (I) Amobarbital
   2. (II) Secobarbital
   3. (III) Pentobarbital
10. C. Any substance which contains any quantity of a
11. D. Chlorhexadol
12. E. Embutramide
13. F. Any drug product containing gamma hydroxybutyric
14. G. Ketamine, its salts, isomer, and salts of isomers (some other names for ketamine: (±)-2-(2-chlorophenyl)-2-(methylamino)- cyclohexanone)
15. H. Lysergic acid
16. I. Lysergic acid amide
17. J. Methyprylon

18. K. Perampanel, and its salts, isomers, and salts of isomers

    1. L. Sulfondiethylmethane
    2. M. Sulfonethylmethane
    3. N. Sulfonmethane
    4. O. Tiletamine and zolazepam or any salt thereof

Some trade or other names for a tiletaminezolazepam combination product: Telazol. Some trade or other names for tiletamine: 2- (ethylamino)-2-(2- thienyl)-cyclohexanone. Some trade or other names for zolazepam: 4-(2-fluorophenyl)- 6-8-dihydro-1,3,8- trimethylpyrazolo-(3,4-e) (1,4)-diazepin- 7(1H)- one, flupyrazapon.

1. 3. Nalorphine
2. 4. Narcotics drugs. Unless specifically excepted or unless

listed in another schedule, any material, compound, mixture, or preparation containing limited quantities of any of the following narcotic drugs or any salts thereof:

1. A. Not more than one and eight tenths grams (1.8gm) of

codeine per one hundred milliliters (100 mL) or not more than ninety milligrams (90 mg) per dosage unit, with an equal or greater quantity of an isoquinoline alkaloid of opium

1. B. Not more than one and eight tenths grams (1.8gm) of

codeine per one hundred milliliters (100 mL) or not more than ninety milligrams (90 mg) per dosage unit, with one (1) or more active, nonnarcotic ingredients in recognized therapeutic amounts

1. C. Not more than one and eight tenths grams (1.8gm)

of dihydrocodeine per one hundred milliliters (100 mL) or not more than ninety milligrams (90 mg) per dosage unit, with one (1) or more active, nonnarcotic ingredients in recognized therapeutic amounts

1. D. Not more than three hundred milligrams (300 mg)

of ethylmorphine per one hundred milliliters (100 mL) or not more than fifteen milligrams (15 mg) per dosage unit, with one (1) or more active, nonnarcotic ingredients in recognized therapeutic amounts

1. E. Not more than five hundred milligrams (500 mg) of

opium per one hundred milliliters (100 mL) or per one hundred grams (100 gm) or not more than twenty-five milligrams (25 mg) per dosage unit, with one (1) or more active nonnarcotic ingredients in recognized therapeutic amounts

1. F. Not more than fifty milligrams (50 mg) of morphine

per one hundred milliliters (100 mL) or per one hundred grams (100 gm), with one (1) or more active, nonnarcotic ingredients in recognized therapeutic amounts

1. 5. Any material, compound, mixture, or preparation

containing any of the following narcotic drugs or their salts, as set forth below:

1. A. Buprenorphine
2. 6. Anabolic steroids. Unless specially excepted or unless

listed in another schedule, any material, compound, mixture, or preparation containing any quantity of the following substances, including its salts, isomers, and salts of isomers whenever the existence of such salts of isomers is possible within the specific chemical designation. DEA has assigned code 4000 for all anabolic steroids. Anabolic steroids. Any drug or hormonal substance, chemically and pharmacologically related to testosterone (other than estrogens, progestins, corticosteroids, and dehydroepiandrosterone) that promotes muscle growth, except an anabolic steroid which is expressly intended for administration through implants to cattle or other nonhuman species and which has been approved by the Secretary of Health and Human Services for that administration. If any person prescribes, dispenses, or distributes such steroid for human use, such person shall be considered to have prescribed, dispensed, or distributed an anabolic steroid 2605 within the meaning of this paragraph. Unless specifically 2610 excepted or unless listed in another schedule, any material, compound, mixture, or preparation containing any quantity of the following substances, including its salts, esters, and ethers:

en-3-one)

en-3-one)

hydroxy-17α-methyl-androst-1, 4-dien-3-one)

en-17β-ol) (a.k.a. madol)

hydroxy-5α-androst-1-en-3-one)

3-one)

dihydroxyandrost-4-en-3-one)

11α,17β-dihydroxyandrost-1,4-dien-3-one)

furazan)

3-one)

4-en-3-one)

3-one)

3-one)

dien-3-one)

ene)

3-one)

en-3-one)

hydroxy-17β-hydroxyestr-4-en-3-one)

4,9(10)-dien-3-one)

4,9,11-trien-3-one)

1. A. 3β,17β-dihydroxy-5α-androstane
2. B. 3α,17β-dihydroxy-5α-androstane
3. C. 5α-androstan-3,17-dione
4. D. 1-androstenediol (3β,17β-dihydroxy-5α-androst-1-ene)
5. E. 1-androstenediol (3α,17β-dihydroxy-5α-androst-1-ene)
6. F. 4-androstenediol (3β,17β-dihydroxy-androst-4-ene)
7. G. 5-androstenediol (3β,17β-dihydroxy-androst-5-ene)
8. H. 1-androstenedione ([5α]-androst-1-en-3,17-dione)
9. I. 4-androstenedione (androst-4-en-3,17-dione)
10. J. 5-androstenedione (androst-5-en-3,17-dione)
11. K. Bolasterone (7α,17α-dimethyl-17β-hydroxyandrost-4-
12. L. Boldenone (17β-hydroxyandrost-1, 4-diene-3-one)
13. M. Boldione (androstra-1,4-diene-3,17-dione)
14. N. Calusterone (7β,17α-dimethyl-17β-hydroxyandrost-4-
15. O. Clostebol (4-chloro-17β-hydroxyandrost-4-en-3-one)
16. P. Dehydrochloromethyltestosterone (4-chloro-17β-
17. Q. Desoxymethyltestosterone (17α-methyl-5α-androst-2-
18. R. Δ1-dihydrotestosterone (a.k.a.’1-testosterone’)(17β-
19. S. 4-dihydrotestosterone (17β-hydroxy-androstan-3-one)
20. T. Drostanolone (17β-hydroxy-2α-methyl-5α-androstan-
21. U. Ethylestrenol (17α-ethyl-17β-hydroxyestr-4-ene)
22. V. Fluoxymesterone (9-fluoro-17α-methyl-11β,17β-
23. W. Formebulone (Formebolone) (2-formyl-17α-methyl-
24. X. Furazabol (17α-methyl-17β-hydroxyandrostano[2,3-c]-
25. Y. 13β-ethyl-17β-hydroxygon-4-en-3-one
26. Z. 4-hydroxytestosterone (4,17β-dihydroxy-androst-4-en-

AA. 4-hydroxy-19-nortestosterone (4,17β-dihydroxy-estr-

BB. Mestanolone (17α-methyl-17β-hydroxy-5α-androstan-

1. CC. Mesterolone (1α-methyl-17β-hydroxy-[5α]-androstan-
2. DD. Methandienone (17α-methyl-17β-hydroxyandrost-1,4-

EE. Methandriol (17α-methyl-3β,17β-dihydroxyandrost-5-

FF. Methasterone (2α,17α-dimethyl-5α-androstan-17β-ol-

GG. Methenolone (1-methyl-17β-hydroxy-5α-androst-1-

HH. 17α-methyl-3β,17β-dihydroxy-5α-androstane II. 17α-methyl-3α,17β-dihydroxy-5α-androstane JJ. 17α-methyl-3β,17β-dihydroxyandrost-4-ene KK. 17α-methyl-4-hydroxynandrolone(17α-methyl-4-

1. LL. Methyldienolone (17α -methyl-17β-hydroxyestra-

2. MM. Methyltrienolone (17α-methyl-17β-hydroxyestra- NN. Methyltestosterone (17α-methyl-17-hydroxyandrost- 4-en-3-one) OO. Mibolerone (7α,17α-dimethyl-17β-hydroxyestr-4-en- 3-one) PP. 17α-methyl-Δ1-dihydrotestosterone (17β-hydroxy-17α- methyl-5α-androst-1-en-3-one) (a.k.a. 17-α-methyl-1-testosterone) QQ. Nandrolone (17β-hydroxyestr-4-ene-3-one) RR. 19-nor-4-androstenediol (3β,17β-dihydroxyestr-4- ene) SS. 19-nor-4-andro stenediol (3α,17β-dihydroxyestr-4- ene) TT. 19-nor-4,9(10)-androstadienedione (estra-4,9(10)- diene-3,17-dione) UU. 19-nor-5-androstenediol (3β,17β-dihydroxyestr-5- ene)

   1. VV. 19-nor-5-androstenediol (3α,17β-dihydroxyestr-5-ene) WW. 19-nor-4-androstenedione (estr-4-en-3,17-dione)
   2. XX. 19-nor-5-androstenedione (estr-5-en-3,17-dione) YY. Norbolethone (13β,17α-diethyl-17β-hydroxygon-4-en-

3-one) ZZ. Norclostebol (4-chloro-17β-hydroxyestr-4-en-3-one) AAA. Norethandrolone (17α-ethyl-17β-hydroxyestr-4-en- 3-one) BBB. Normethandrolone (17α-methyl-17β-hydroxyestr-4- en-3-one)

1. CCC. Oxandrolone (17α-methyl-17β-hydroxy-2-oxa-[5α]-

androstan-3-one)

1. DDD. Oxymesterone (17α-methyl-4,17β-dihydroxyandrost-

4-en-3-one) EEE. Oxymetholone (17α-methyl-2-hydroxymethylene- 17β-hydroxy-[5α]-androstan-3-one) FFF. Prostanozol (17β-hydroxy-5α-androstano[3,2-c] pyrazole) GGG. Stanolone (Δ1-dihydrotestosterone (a.k.a. 1-testosterone)(17β-hydroxy-5α-androst-1-en-3-one)) HHH. Stanozolol (17α-methyl-17β-hydroxy-[5α]-androst-2- eno[3,2-c]-pyrazole)

1. III. Stenbolone (17β-hydroxy-2-methyl-[5α]-androst-1-en-

3-one) JJJ. Testolactone(13-hydroxy-3-oxo-13,17-secoandrosta-1,4- dien-17-oic acid lactone) KKK. Testosterone(17β-hydroxyandrost-4-en-3-one);

1. LLL. Tetrahydrogestrinone (13β ,17α-diethyl-17β -

hydroxygon-4,9, 11-trien-3-one)

1. MMM. Trenbolone (17β-hydroxyestr-4,9,11-trien-3-one) NNN. Any salt, ester, or isomer of a drug or substance

described or listed in this subparagraph, if that salt, ester, or isomer promotes muscle growth except an anabolic steroid which is expressly intended for administration through implants to cattle or other nonhuman species and which has been approved by the Secretary of Health and Human Services for that administration.

1. 7. Dronabinol (synthetic) in sesame oil and encapsulated

in a soft gelatin capsule in a United States Food and Drug Administration approved drug product 7369 (Some other names for dronabinol: (6aRtrans)- 6a,7,8,10atetrahydro-6.6.9-trimethyl-3-pentyl-6H-dibenzo (b,d) pyran- 1-ol, or (-) -delta-9-(trans)-tetrahydrocannabinol.)

1. (D) Schedule IV shall consist of the drugs and other substances, by whatever official name, common or usual name, chemical name, or brand name designated, listed in this subsection. Each drug or substance has been assigned the DEA Controlled Substances Code Number set forth opposite it.

   1. 1. Narcotic drugs. Unless specifically excepted or unless

listed in another schedule, any material, compound, mixture, or preparation containing limited quantities of any of the following narcotic drugs or any salts thereof:

1. A. Not more than one milligram (1 mg) of difenoxin (DEA

Drug Code No. 9168) and not less than twenty-five micrograms (25 mcg) of atropine sulfate per dosage unit

1. B. Dextropropoxyphene (alpha-(+)-4-dimethylamino-1,2-

diphenyl-3-methyl-2-propionoxybutane)

1. C. 2-[(dimethylamino)methyl]-1-(3-methoxyphenyl)

cyclohexanol, its salts, optical and geometric isomers, and salts of these isomers (including tramadol)

1. D. Narcotic drugs containing nonnarcotic active

medicinal ingredients. Any compound, mixture, or preparation containing any of the following limited quantities of narcotic drugs or salts thereof, which shall include one (1) or more nonnarcotic active medicinal ingredients in sufficient proportion to confer upon the compound, mixture, or preparation valuable medicinal qualities other than those possessed by the narcotic drug alone:

1. (I) Not more than two hundred milligrams (200 mg)

of codeine per one hundred milliliters (100 mL) or per one hundred grams (100 gm);

1. (II) Not more than one hundred milligrams (100 mg) of

dihydrocodeine per one hundred milliliters (100 mL) or per one hundred grams (100 gm); or

1. (III) Not more than one hundred milligrams (100 mg)

of ethylmorphine per one hundred milliliters (100 mL) or per one hundred grams (100 gm).

1. 2. Depressants. Unless specifically excepted or unless

listed in another schedule, any material, compound, mixture, or preparation which contains any quantity of the following substances, including its salts, isomers, and salts of isomers whenever the existence of such salts, isomers, and salts of isomers is possible within the specific chemical designation:

1. A. Alfaxalone
2. B. Alprazolam
3. C. Barbital
4. D. Brexanolone
5. E. Bromazepam
6. F. Camazepam
7. G. Carisoprodol
8. H. Chloral betaine
9. I. Chloral hydrate
10. J. Chlordiazepoxide
11. K. Clobazam
12. L. Clonazepam
13. M. Clorazepate
14. N. Clotiazepam
15. O. Cloxazolam
16. P. Daridorexant
17. Q. Delorazepam
18. R. Diazepam
19. S. Dichloralphenazone
20. T. Estazolam
21. U. Ethchlorvynol
22. V. Ethinamate
23. W. Ethyl loflazepate
24. X. Fludiazepam
25. Y. Flunitrazepam
26. Z. Flurazepam AA. Fospropofol BB. Halazepam
27. CC. Haloxazolam

28. DD. Ketazolam EE. Lemborexant FF. Loprazolam GG. Lorazepam HH. Lormetazepam

    1. II. Mebutamate JJ. Medazepam KK. Meprobamate
    2. LL. Methohexital
    3. MM. Methylphenobarbital (Mephobarbital) NN. Midazolam OO. Nimetazepam PP. Nitrazepam QQ. Nordiazepam RR. Oxazepam SS. Oxazolam TT. Paraldehyde UU. Petrichloral
    4. VV. Phenobarbital WW. Pinazepam
    5. XX. Prazepam YY. Quazepam ZZ. Remimazolam AAA. Suvorexant BBB. Temazepam
    6. CCC. Tetrazepam
    7. DDD. Triazolam EEE. Zaleplon FFF. Zolpidem GGG. Zopiclone
29. 3. Fenfluramine. Any material, compound, mixture, or

preparation which contains any quantity of the following substances, including its salts, isomers (whether optical, position, or geometric), and salts of such isomers, whenever the existence of such salts, isomers, and salts of isomers is possible:

1. A. Fenfluramine
2. 4. Lorcaserin. Any material, compound, mixture, or

preparation which contains any quantity of the following substances, including its salts, isomers, and salts of isomers, whenever the existence of such salts, isomers, and salts of isomers is possible:

1. A. Lorcaserin
2. 5. Stimulants. Unless specifically excepted or unless

listed in another schedule, any material, compound, mixture, or preparation which contains any quantity of the following substances having a stimulant effect on the central nervous system, including its salts, isomers, and salts of isomers:

1. A. Cathine ((+)-norpseudoephedrine)
2. B. Diethylpropion
3. C. Fencamfamin
4. D. Fenproporex
5. E. Mazindol
6. F. Mefenorex
7. G. Modafinil
8. H. Pemoline (including organometallic complexes and chelates thereof)
9. I. Phentermine
10. J. Pipradrol
11. K. Serdexmethylphenidate
12. L. Sibutramine
13. M. Solriamfetol (2-amino-3-phenylpropyl carbamate; benzenepropanol, betaamino-, carbamate (ester))
14. N. SPA (-)-1-dimethylamino-1,2-diphenylethane
15. 6. Other substances. Unless specifically excepted or unless

listed in another schedule, any material, compound, mixture, or preparation which contains any quantity of the following substances, including its salts: 2837 7. Ephedrine. Any material, compound, mixture, or 2834 preparation which contains any quantity of the following 2838 substances having a stimulant effect on the central nervous 2835 system including their salts, isomers, and salts of isomers:

optical isomers as the only active medicinal ingredient or contains ephedrine or its salts, optical isomers, or salts of optical isomers and therapeutically insignificant quantities of another active medicinal ingredient.

2764 (E) Schedule V shall consist of the drugs and other substances, 2881 by whatever official name, common or usual name, chemical 2846 name, or brand name designated, listed in this subsection. 2223 1. Narcotic drugs containing nonnarcotic active medicinal 2925 ingredients. Any compound, mixture, or preparation containing 2886 any of the following narcotic drugs, or their salts calculated as 2887 the free anhydrous base or alkaloid, in limited quantities as 2781 follows, which shall include one (1) or more nonnarcotic active 2783 medicinal ingredients in sufficient proportion to confer upon the compound, mixture, or preparation valuable medicinal qualities other than those possessed by the narcotic drug alone:

of codeine per one hundred milliliters (100 mL) or per one hundred grams (100 gm);

1670 dihydrocodeine per one hundred milliliters (100 mL) or per one hundred grams (100 gm);

ethylmorphine per one hundred milliliters (100 mL) or per one hundred grams (100 gm);

1625 of diphenoxylate and not less than twenty-five micrograms (25 mcg) of atropine sulfate per dosage unit;

opium per one hundred milliliters (100 mL) or per one hundred grams (100 gm); and

difenoxin (DEA Drug Code No. 9168) and not less than twenty-

1610 five micrograms (25 mcg) of atropine sulfate per dosage unit. 1760 2. Stimulants. Unless specifically exempted or excluded 1575 or unless listed in another schedule, any material, compound, 1605 mixture, or preparation which contains any quantity of the 1580 following substances having a stimulant effect on the central 1680 nervous system including its salts, isomers, and salts of isomers:

1640 3. Any compound, mixture, or preparation containing any 1750 detectable quantity of pseudoephedrine or its salts or optical 1729 isomers, or salts of optical isomers or any compound, mixture, 1675 or preparation containing any detectable quantity of ephedrine or its salts or optical isomers, or salts of optical isomers if the drug preparations are starch-based solid dose forms, if such preparations are sold over the counter without a prescription. The following drug preparations containing ephedrine and pseudoephedrine are not scheduled controlled substances:

to be dispensed.

1. A. Pentazocine 9709
2. B. Butorphanol (including its optical isomers) 9720
3. C. Eluxadoline (5-[[[(2S)-2-amino-3-[4- aminocarbonyl)-2,6-dimethylphenyl]-1- oxopropyl] [(1S)-1-(4-phenyl-1 H-imidazol-2- yl)ethyl]amino]methyl]-2-methoxybenzoic acid) (including its optical isomers) and its salts, isomers, and salts of isomers 9725
4. A. Ephedrine or its salts, optical isomers, or salts of
5. A. Not more than two hundred milligrams (200 mg)
6. B. Not more than one hundred milligrams (100 mg) of
7. C. Not more than one hundred milligrams (100 mg) of
8. D. Not more than two and five-tenths milligrams (2.5 mg)
9. E. Not more than one hundred milligrams (100 mg) of
10. F. Not more than five-tenths milligram (0.5 mg) of
11. A. Pyrovalerone 1485
12. A. Drug preparations in liquid form; and

13. B. Drug preparations that require a prescription in order

    1. 4. Unless specifically exempted or excluded or unless

listed in another schedule, any material, compound, mixture, or preparation which contains any quantity of the following substances having a depressant effect on the central nervous system, including its salts:

1. A. Ezogabine [N-[2-amino-4(4- fluorobenzylamino)-phenyl]- carbamic acid ethyl ester]
2. B. Ganaxolone (3α-hydroxy-3β-methyl- 5α-pregnan-20-one)
3. C. Lacosamide [(R)-2-acetoamido-N-benzyl- 3-methoxy-propionamide]
4. D. Pregabalin [(S)-3-(aminomethyl)-5- methylhexanoic acid]
5. E. Brivaracetam ((25)-2-[(4R)- 2-oxo-4-propylpyrrolidin-1- yl]butanamide) (also referred to as BRV; UCB-34714; Briviact)
6. F. Lasmiditan [2,4,6-trifluoro-N-(6-(1- methylpiperidine-4-carbonyl) pyridine-2- yl-benzamide]
7. G. Cenobamate ([(1R)-1-(2- chlorophenyl)-2-(tetrazol- 2-yl)ethyl] carbamate; 2H- tetrazole-2-ethanol, alpha-(2- chlorophenyl)-, carbamate (ester), (alphaR)-; carbamic acid (R)-(+)-1-(2-chlorophenyl)-2-(2H-tetrazol- 2-yl)ethyl ester)

1. (2) Excluded Nonnarcotic Substances. The following nonnarcotic substances which, under the Federal Food, Drug, and Cosmetic Act (21 U.S.C. 301) and section 201(g)(1) of the federal Controlled Substances Act (21 U.S.C. 811(g)(1)), may be lawfully sold over the counter without a prescription, are excluded from all schedules pursuant to section 195.015(5), RSMo. Company

Bioline Laboratories Aphena Pharma Solutions—New York, LLC Goldline Laboratories Goldline Laboratories Hawthorne Products, Inc. Parke-Davis & Co. Parke-Davis & Co. Parke-Davis & Co. Parke-Davis & Co. Parmed Pharmacy Rondex Labs Smith Kline Consumer Sterling Drug, Inc. Sterling Drug, Inc. Vicks Chemical Co. White Hall Labs

AUTHORITY: section 195.015, RSMo Supp. 2022, and section 195.195, RSMo 2016.* Material found in this rule previously filed as 19 CSR 30-1.010. Original rule filed April 14, 2000, effective Nov. 30, 2000. Amended: Filed Jan. 31, 2003, effective July 30, 2003. Amended: Filed Sept. 30, 2016, effective May 30, 2017. Emergency amendment filed Oct. 25, 2018, effective Nov. 4, 2018, expired May 2, 2019. Amended: Filed Oct. 25, 2018, effective April 30, 2019. Emergency amendment filed Oct. 30, 2020, effective Nov. 16, 2020, expired May 14, 2021. Amended: Filed Oct. 30, 2020, effective April 30, 2021. Emergency amendment filed Sept. 28, 2021, effective Oct. 13, 2021, expired April 10, 2022. Amended: Filed Sept. 28, 2021, effective March 30, 2022. Emergency amendment filed Sept. 12, 2022, effective Oct. 3, 2022, expired March 31, 2023. Amended: Filed Sept. 12, 2022, effective March 30, 2023. *Original authority: 195.015, RSMo 1971, amended 1989, 2014, 2020, and 195.195, RSMo 1957, amended 1971, 1989, 1993, 2014.